Skip to main content

Repotrectinib

Generic name: repotrectinib [ RE-poe-TREK-ti-nib ]
Brand name: Augtyro
Dosage form: oral capsule (160 mg; 40 mg)
Drug class: Multikinase inhibitors

Medically reviewed by Drugs.com on Dec 23, 2024. Written by Cerner Multum.

What is repotrectinib?

Repotrectinib is used in adults to treat non-small cell lung cancer that has spread within your chest or to other parts of the body (metastatic).

Repotrectinib is also used in adults and children at least 12 years old who have tumors (cancer) that have spread to other parts of the body (metastatic), cannot be removed with surgery, or when other treatments did not work or stopped working.

Your doctor will make sure you have the correct tumor type to be treated with repotrectinib.

Repotrectinib may also be used for purposes not listed in this medication guide.

Repotrectinib side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Repotrectinib may cause serious side effects. Call your doctor at once if you have:

Your cancer treatments may be delayed, reduced, or permanently discontinued if you have certain side effects.

Common side effects of repotrectinib may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

Call your doctor if you have nervous system problems such as dizziness, vertigo (spinning sensation), mood changes, loss of balance or coordination, problems with thinking, memory or concentration, hallucinations, or trouble sleeping.

Before taking this medicine

Tell your doctor if you have or have ever had:

You may be more likely to have a broken bone while using repotrectinib. Talk with your doctor about ways to keep your bones healthy.

Repotrectinib can make hormonal birth control less effective, including birth control pills, injections, implants, skin patches, and vaginal rings. Use non-hormonal birth control to prevent pregnancy: condom, diaphragm, cervical cap, or contraceptive sponge.

Ask your doctor about the best form of birth control while you are using repotrectinib.

Repotrectinib can harm an unborn baby if the mother or the father is using repotrectinib.

Do not breastfeed while using this medicine, and for at least 10 days after your last dose.

How should I take repotrectinib?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Do not change your dose or stop using repotrectinib without your doctor's advice. Use the medicine exactly as directed.

You may take repotrectinib with or without food, but take it the same way each time.

Swallow the capsule whole with water and do not crush, chew, break, or open it. Do not take a capsule that is damaged in any way.

You will need frequent medical tests before and during treatment with repotrectinib, and your next dose may be delayed, reduced, or permanently discontinued based on the results.

You may be given other medications to help prevent serious side effects. Keep taking these medicines for as long as your doctor has prescribed. Your doctor will monitor you for these side effects.

If you vomit shortly after taking repotrectinib, do not take another dose. Take your next dose as scheduled.

Store at room temperature away from moisture and heat.

Repotrectinib dosing information

Usual Adult Dose for Non-Small Cell Lung Cancer:

Initial dose: 160 mg orally once a day for 14 days
Maintenance dose: 160 mg orally twice a day

Duration of therapy: Until disease progression or unacceptable toxicity

Comments:
-Patients should be selected based on the presence of ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) rearrangement(s) in tumor specimens. The US FDA-approved test to detect ROS1 rearrangements is currently not available.
-Treatment with strong and moderate CYP450 3A inhibitors should be stopped for 3 to 5 elimination half-lives before starting this drug.

Use: For the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer

What happens if I miss a dose?

Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking repotrectinib?

Grapefruit may interact with repotrectinib and cause side effects. Avoid consuming grapefruit products.

Avoid driving or hazardous activity until you know how repotrectinib will affect you. This medicine may cause dizziness, blurred vision, balance or memory problems and this may impair your reactions or cause falls, accidents, or severe injuries.

What other drugs will affect repotrectinib?

Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.

Tell your doctor about all your other medicines, especially:

Other drugs may affect repotrectinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Does repotrectinib interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.